Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 74

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 74
---
 have been prepared in accordance with accounting principles generally accepted in the United States of America. All intercompany balances and transactions have been eliminated in consolidation. The accompanying statements of operations include expenses for certain functions historically performed by the Parent company, including general corporate services, such as legal, accounting, treasury, information technology, human resources and administration. These expenses are based primarily on direct usage when identifiable, direct capital expenditures or other relevant allocations during the respective periods. We believe the assumptions underlying the accompanying condensed consolidated financial statements, including the assumptions regarding these expenses from this related party, are reasonable. Actual results may differ from these expenses, assumptions and estimates. The amounts recorded in the accompanying condensed consolidated financial statements are not necessarily indicative of the actual amount of such indirect expenses that would have been recorded had we been a separate independent entity. F-8

Restatement of Previously Issued Financials

After the initial issuance of the Company’s 2023 financial statements on March 18, 2024, management reconsidered the estimate previously applied. The impact of the adjustments is listed in the notes below. The following table summarizes the impacts of the changes in estimates on the Company’s financial statements for each of the periods presented below:

The following table summarizes the impact of the changes in estimates on the Company’s financial statements for the year ended December 31, 2023:

|                                                                                                                                          |     | Impact of changes in estimates 
 As previously                  
 reported                       |         |   |     | Adjustments |        |   |     | As restated  
 December 31, 
 2023         |         |   |
|:-----------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------------------------|--------:|:--|:----|:------------|-------:|:--|:----|:-------------|--------:|:--|
| Assets                                                                                                                                   |     |                                |         |   |     |             |        |   |     |              |         |   |
| Cash and cash equivalents                                                                                                                |     | $                              |   1,234 |   |     | $           |      - |   |     | $            |   1,234 |   |
| Accounts receivable (i)                                                                                                                  |     |                                |   3,236 |   |     |             |    359 |   |     |              |   3,595 |   |
| Other current assets (ii)                                                                                                                |     |                                |   1,259 |   |     |             |   (435